Matches in Nanopublications for { ?s ?p "[Since activating K-ras mutations are described in more than 80% of pancreatic cancers and are known to increase intracellular levels of p21WAF1/CIP1 in experimental models, the possible role of activating K-ras mutations in an induction of the p21WAF1/CIP1 expression was investigated in our study.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP593362.RAshwjRq2tjyXVbVp892Ta4TjNhkJIocyogxFj5X2t0oE130_assertion description "[Since activating K-ras mutations are described in more than 80% of pancreatic cancers and are known to increase intracellular levels of p21WAF1/CIP1 in experimental models, the possible role of activating K-ras mutations in an induction of the p21WAF1/CIP1 expression was investigated in our study.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593362.RAshwjRq2tjyXVbVp892Ta4TjNhkJIocyogxFj5X2t0oE130_provenance.
- NP302733.RAXOiA6hUGXaXLLz57mGaIEZupTOpQ7F_IOtTLqzfcM8I130_assertion description "[Since activating K-ras mutations are described in more than 80% of pancreatic cancers and are known to increase intracellular levels of p21WAF1/CIP1 in experimental models, the possible role of activating K-ras mutations in an induction of the p21WAF1/CIP1 expression was investigated in our study.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP302733.RAXOiA6hUGXaXLLz57mGaIEZupTOpQ7F_IOtTLqzfcM8I130_provenance.
- NP760607.RAPkL5mNHryZdGLP4BGQwrNX9zGm2N0SyxfoN574xswjc130_assertion description "[Since activating K-ras mutations are described in more than 80% of pancreatic cancers and are known to increase intracellular levels of p21WAF1/CIP1 in experimental models, the possible role of activating K-ras mutations in an induction of the p21WAF1/CIP1 expression was investigated in our study.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP760607.RAPkL5mNHryZdGLP4BGQwrNX9zGm2N0SyxfoN574xswjc130_provenance.
- NP926395.RAlXQJo8VrOUKpWt5SuNwrI8bYsDuzfK-coYh_ZJ64BUM130_assertion description "[Since activating K-ras mutations are described in more than 80% of pancreatic cancers and are known to increase intracellular levels of p21WAF1/CIP1 in experimental models, the possible role of activating K-ras mutations in an induction of the p21WAF1/CIP1 expression was investigated in our study.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926395.RAlXQJo8VrOUKpWt5SuNwrI8bYsDuzfK-coYh_ZJ64BUM130_provenance.
- NP421225.RAopyBlPZq7hOtQBYvXSkmRSqHVNxTG-CGT8h9tYLkVqg130_assertion description "[Since activating K-ras mutations are described in more than 80% of pancreatic cancers and are known to increase intracellular levels of p21WAF1/CIP1 in experimental models, the possible role of activating K-ras mutations in an induction of the p21WAF1/CIP1 expression was investigated in our study.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP421225.RAopyBlPZq7hOtQBYvXSkmRSqHVNxTG-CGT8h9tYLkVqg130_provenance.
- NP421227.RA7-QIOjEWYczxysmm36uz05VAHKR8hGgLu5CJZjxI5f4130_assertion description "[Since activating K-ras mutations are described in more than 80% of pancreatic cancers and are known to increase intracellular levels of p21WAF1/CIP1 in experimental models, the possible role of activating K-ras mutations in an induction of the p21WAF1/CIP1 expression was investigated in our study.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP421227.RA7-QIOjEWYczxysmm36uz05VAHKR8hGgLu5CJZjxI5f4130_provenance.